150 related articles for article (PubMed ID: 22037022)
1. Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff's base to overcome MDR in cancer.
Basu S; Ganguly A; Chakraborty P; Sen R; Banerjee K; Chatterjee M; Efferth T; Choudhuri SK
Biochimie; 2012 Jan; 94(1):166-83. PubMed ID: 22037022
[TBL] [Abstract][Full Text] [Related]
2. Induction of intrinsic and extrinsic apoptosis through oxidative stress in drug-resistant cancer by a newly synthesized Schiff base copper chelate.
Banerjee K; Basu S; Das S; Sinha A; Biswas MK; Choudhuri SK
Free Radic Res; 2016; 50(4):426-46. PubMed ID: 26733073
[TBL] [Abstract][Full Text] [Related]
3. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis.
Ganguly A; Basu S; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Chaudhuri SK
Mol Biosyst; 2011 May; 7(5):1701-12. PubMed ID: 21409205
[TBL] [Abstract][Full Text] [Related]
4. Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative.
Ganguly A; Banerjee K; Chakraborty P; Das S; Sarkar A; Hazra A; Banerjee M; Maity A; Chatterjee M; Mondal NB; Choudhuri SK
Biomed Pharmacother; 2011 Sep; 65(6):387-94. PubMed ID: 21715129
[TBL] [Abstract][Full Text] [Related]
5. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Majumder S; Dutta P; Mookerjee A; Choudhuri SK
Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
[TBL] [Abstract][Full Text] [Related]
6. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro.
Banerjee K; Biswas MK; Choudhuri SK
J Biol Inorg Chem; 2017 Dec; 22(8):1223-1249. PubMed ID: 29063196
[TBL] [Abstract][Full Text] [Related]
7. An in vitro and in vivo study of a novel zinc complex, zinc N-(2-hydroxyacetophenone)glycinate to overcome multidrug resistance in cancer.
Ghosh RD; Das S; Ganguly A; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Nanda A; Pradhan K; Choudhuri SK
Dalton Trans; 2011 Nov; 40(41):10873-84. PubMed ID: 21717020
[TBL] [Abstract][Full Text] [Related]
8. The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer.
Ganguly A; Chakraborty P; Banerjee K; Choudhuri SK
Eur J Pharm Sci; 2014 Jan; 51():96-109. PubMed ID: 24044945
[TBL] [Abstract][Full Text] [Related]
9. Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate.
Ganguly A; Basu S; Chakraborty P; Chatterjee S; Sarkar A; Chatterjee M; Choudhuri SK
PLoS One; 2010 Jun; 5(6):e11253. PubMed ID: 20582168
[TBL] [Abstract][Full Text] [Related]
10. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.
Efferth T; Giaisi M; Merling A; Krammer PH; Li-Weber M
PLoS One; 2007 Aug; 2(8):e693. PubMed ID: 17668070
[TBL] [Abstract][Full Text] [Related]
11. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells.
Friesen C; Kiess Y; Debatin KM
Cell Death Differ; 2004 Jul; 11 Suppl 1():S73-85. PubMed ID: 15105835
[TBL] [Abstract][Full Text] [Related]
12. A novel manganese complex, Mn-(II) N-(2-hydroxy acetophenone) glycinate overcomes multidrug-resistance in cancer.
Ghosh RD; Banerjee K; Das S; Ganguly A; Chakraborty P; Sarkar A; Chatterjee M; Choudhuri SK
Eur J Pharm Sci; 2013 Jul; 49(4):737-47. PubMed ID: 23665413
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
[TBL] [Abstract][Full Text] [Related]
14. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial alterations induced by serum amine oxidase and spermine on human multidrug resistant tumor cells.
Arancia G; Calcabrini A; Marra M; Crateri P; Artico M; Martone A; Martelli F; Agostinelli E
Amino Acids; 2004 Jun; 26(3):273-82. PubMed ID: 15221508
[TBL] [Abstract][Full Text] [Related]
16. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
17. Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Ganguly A; Chakraborty P; Banerjee K; Chatterjee S; Basu S; Sarkar A; Chatterjee M; Choudhuri SK
Biometals; 2012 Feb; 25(1):149-63. PubMed ID: 21915630
[TBL] [Abstract][Full Text] [Related]
18. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
19. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
[TBL] [Abstract][Full Text] [Related]
20. Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations.
Meurette O; Lefeuvre-Orfila L; Rebillard A; Lagadic-Gossmann D; Dimanche-Boitrel MT
Clin Cancer Res; 2005 Apr; 11(8):3075-83. PubMed ID: 15837763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]